ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

ACS Modifies Mammography Guidelines

August 5, 1983

Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter

October 15, 1976

Antidepressant Provides Cool Choice For Hot Flashes

February 22, 2002

NIH “Just In Time” Procedure Expanded For Two Awards

April 12, 1996

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014